Literature DB >> 9150448

Regulation of vascular morphogenesis by the matricellular protein SPARC.

K Motamed1, E H Sage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9150448     DOI： 10.1038/ki.1997.189

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  8 in total

1.  SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.

Authors:  S A Rempel; W A Golembieski; J L Fisher; M Maile; A Nakeff
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy.

Authors:  Isabella T Tai; Meiru Dai; David A Owen; Lan Bo Chen
Journal:  J Clin Invest       Date:  2005-05-12       Impact factor: 14.808

3.  Secreted cathepsin L generates endostatin from collagen XVIII.

Authors:  U Felbor; L Dreier; R A Bryant; H L Ploegh; B R Olsen; W Mothes
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

4.  SPARC/osteonectin mRNA is induced in blood vessels following injury to the adult rat cerebral cortex.

Authors:  D B Mendis; G O Ivy; I R Brown
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

5.  Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.

Authors:  Shanna Arnold; Emilia Mira; Sabeeha Muneer; Grzegorz Korpanty; Adam W Beck; Shane E Holloway; Santos Mañes; Rolf A Brekken
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-29

6.  Sparc (Osteonectin) functions in morphogenesis of the pharyngeal skeleton and inner ear.

Authors:  Josep Rotllant; Dong Liu; Yin-Lin Yan; John H Postlethwait; Monte Westerfield; Shao-Jun Du
Journal:  Matrix Biol       Date:  2008-03-15       Impact factor: 11.583

7.  Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.

Authors:  Cho Rong Park; Jung Hwan Jo; Myung Geun Song; Ji Yong Park; Young-Hwa Kim; Hyewon Youn; Sun Ha Paek; June-Key Chung; Jae Min Jeong; Yun-Sang Lee; Keon Wook Kang
Journal:  Theranostics       Date:  2019-10-11       Impact factor: 11.556

8.  Aberrant methylation of SPARC in human lung cancers.

Authors:  M Suzuki; C Hao; T Takahashi; H Shigematsu; N Shivapurkar; U G Sathyanarayana; T Iizasa; T Fujisawa; K Hiroshima; A F Gazdar
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.